Skip to main content
Log in

Verlaufsformen und Mikrobiologie der bakteriellen Osteomyelitis

  • Leitthema
  • Published:
Der Orthopäde Aims and scope Submit manuscript

Zusammenfassung

Wegen der vielfältigen klinischen Präsentation der Osteomyelitis werden diese Patienten von Ärzten verschiedenster Fachrichtungen gesehen. Verschiedene Klassifikationen spiegeln die Konzepte zur Diagnostik und Therapie der Osteomyelitis wider. Ursprünglich wurde die Osteomyelitis nur in eine akute und eine chronische eingeteilt. Die klassische Einteilung nach Waldvogel berücksichtigt die Pathogenese. Nach Wagner wird beim diabetischen Fuß der fließende Übergang von der Weichteilinfektion zur Osteomyelitis und zur Gangrän beschrieben. Die Einteilung nach Cierny-Mader nützt v. a. der Therapie durch den Traumatologen/Orthopäden. Das Erregerspektrum ist abhängig von Art der Osteomyelitis, geographischer Epidemiologie, Patientenalter, Komorbidität, mikrobiologischer Technik und Infektionsdauer. S. aureus spielt bei jeder Form die wichtigste Rolle. Bei Bildung von Biofilm und „small-colony variants“ neigt der Keim zu Persistenz und Rezidiv. Die Antibiotikaresistenz nimmt seit 20 Jahren zu. Nicht nur die In-vitro-Resistenz, sondern auch die Wirkung der Antibiotika auf nichtwachsende und adhärierende Keime bei Implantatinfektionen sind wichtig. Zur optimalen Antibiotikatherapie sollte immer der Keimnachweis versucht werden.

Abstract

The clinical presentation of osteomyelitis is multifarious. Therefore, patients are diagnosed and treated by various specialists with many different concepts of optimal management. Originally, only the acute and the chronic presentations were differentiated. The classification of Waldvogel, which is based on pathogenetic mechanisms, is more sophisticated. Diabetic foot is classified according to Wagner, who takes into account the continuous progression from sore to ulcer to osteomyelitis to gangrene. The staging according to Cierny-Mader is the most useful for the therapeutic management by surgeons. The spectrum of microorganisms is variable according to the type of osteomyelitis, epidemiology, age of the patient, co-morbidity, microbiological technique (culture, PCR), and duration of the infection. S. aureus is the leading pathogen in each type of osteomyelitis. Over the past 20 years, antimicrobial resistance has become an increasing problem. In case of osteomyelitis, standard susceptibility testing can be inaccurate. In case of device-related infection or in any type of chronic osteomyelitis, antimicrobial agents must be efficacious on stationary-phase and adhering microorganisms. Microbiologic culture and susceptibility testing should always be performed, in order to optimize the antimicrobial therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Altwegg M, Fleisch-Marx A, Goldenberger D, Hailemariam S, Schaffner A, Kissling R (1996) Spondylodiscitis caused by Tropheryma whippelii. Schweiz Med Wochenschr 126: 1495–1499

    CAS  PubMed  Google Scholar 

  2. Kälicke T, Schlegel U, Kraft C, Wingenfeld C, Muhr G, Arens S (2004) Tierexperimentelle Osteitismodelle. Orthopäde 33: 3

    Google Scholar 

  3. Chambers JB, Forsythe DA, Bertrand SL, Iwinski HJ, Steflik DE (2000) Retrospective review of osteoarticular infections in a pediatric sickle cell age group. J Pediatr Orthop 20: 682–685

    CAS  PubMed  Google Scholar 

  4. Cierny G, Mader JT, Pennick H (1985) A clinical staging system of adult osteomyelitis. Contemp Orthop 10: 17–37

    Google Scholar 

  5. Colmenero JD, Jiménez-Mejias ME, Sánchez-Lora FJ, Reguera JM, Palomino-Nicás J, Martos F, Garcia de las Heras J, Pachón J (1997) Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis 56: 709–715

    PubMed  Google Scholar 

  6. Darouiche RO, Raad II, Heard SO et al. (1999) A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 340: 1–8

    CAS  PubMed  Google Scholar 

  7. Esolen LM, Fasano MB, Flynn J, Burton A, Lederman HM (1992) Pneumocystis carinii osteomyelitis in a patient with common variable immunodeficiency. N Engl J Med 326: 999–1001

    CAS  PubMed  Google Scholar 

  8. Fluckiger U, Widmer AF (1999) Epidemiology of methicillin-resistant Staphylococcus aureus. Chemotherapy 45: 121–134

    Article  CAS  PubMed  Google Scholar 

  9. Gristina AG, Oga M, Webb LX, Hobgood CD (1985) Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 228: 990–993

    CAS  PubMed  Google Scholar 

  10. Haas DW, McAndrew MP (1996) Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med 101: 550–561

    Article  PubMed  Google Scholar 

  11. Harnett N, Brown S, Krishnan C (1991) Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada. Antimicrob Agents Chemother 35: 1911–1913

    CAS  PubMed  Google Scholar 

  12. Lew DP, Waldvogel FA (1997) Osteomyelitis. N Engl J Med 336: 999–1007

    CAS  PubMed  Google Scholar 

  13. Ley BE, Linton CJ, Bennet DM, Jalal H, Foot AB, Millar MR (1998) Detection of bacteraemia in patients with fever and neutropenia using 16 S rRNA gene amplification by polymerase chain reaction. Eur J Clin Microbiol Infect Dis 17: 247–253

    Article  CAS  PubMed  Google Scholar 

  14. Mader JT, Shirtliff M, Calhoun JH (1997) Staging and staging application in osteomyelitis. Clin Infect Dis 25: 1303–1309

    CAS  PubMed  Google Scholar 

  15. Proctor RA, Peters G (1998) Small colony variants in staphylococcal infections: diagnostic an therapeutic implications. Clin Infect Dis 27: 419–423

    CAS  PubMed  Google Scholar 

  16. Robson JM, Harte GJ, Osborne DR, McCormack JG (1999) Cat-scratch disease with paravertebral mass and osteomyelitis. Clin Infect Dis 28: 274–278

    Google Scholar 

  17. Steckelberg JM, Osmon DR (2000) Prosthetic joint infections. In: Waldvogel FA, Bisno AL (eds) Infections associated with indwelling medical devices. ASM Press, Washington/DC, pp 173–209

  18. Stewart PS, Costerton WJ (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358: 135–138

    Article  CAS  PubMed  Google Scholar 

  19. Trucksis M, Hooper DC, Wolfson JS (1991) Emerging resistance to fluoroquinolones in staphylococci: an alert. Ann Intern Med 114: 424–426

    CAS  PubMed  Google Scholar 

  20. Vaudaux P, François P, Lew DP, Waldvogel FA (2000) Host factors predisposing to and influencing therapy of foreign body infections. In: Infections associated with indwelling medical devices. Waldvogel FA, Bisno AL (eds), ASM Press. Washington/DC, pp 1–26

  21. Von Eiff C, Bettin D, Proctor RA, Rolauffs B, Lindner N, Winkelmann W, Peters G (1997) Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 25: 1250–1251

    PubMed  Google Scholar 

  22. Von Eiff C, Proctor RA, Peters G (2000) Staphylococcus aureus small colony variants: formation and clinical impact. Int J Clin Pract 115 (Suppl): 44–49

    Google Scholar 

  23. Wagner FW (1981) The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2: 64–122

    PubMed  Google Scholar 

  24. Waldvogel FA (1989) Use of quinolones for the treatment of osteomyelitis and septic arthritis. Rev Infect Dis 11 (Suppl 5): S1259–S1263

    PubMed  Google Scholar 

  25. Waldvogel FA, Medoff G, Swartz MN (1970) Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 282: 198–206

    CAS  PubMed  Google Scholar 

  26. Wheat JL, Allen SD, Henry M et al. (1986) Diabetic foot infections. Arch Intern Med 146: 1935–1340

    Article  CAS  PubMed  Google Scholar 

  27. Widmer AF, Wiestner A, Frei R, Zimmerli W (1991) Killing of non-growing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 35: 741–746

    CAS  PubMed  Google Scholar 

  28. Zimmerli W, Frei R, Widmer AF, Rajacic Z (1994) Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 33: 959–967

    CAS  PubMed  Google Scholar 

  29. Zimmerli W, Ochsner PE (2003) Management of infection associated with prosthetic joints. Infection 31: 99–108

    Google Scholar 

  30. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE for the FBI-study group (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: randomized controlled clinical trial. JAMA 279: 1537–1541

    CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Zimmerli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimmerli, W., Flückiger, U. Verlaufsformen und Mikrobiologie der bakteriellen Osteomyelitis. Orthopäde 33, 267–272 (2004). https://doi.org/10.1007/s00132-003-0604-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00132-003-0604-1

Schlüsselwörter

Keywords

Navigation